Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Debt (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Debt for 3 consecutive years, with $42.3 million as the latest value for Q1 2026.

  • Quarterly Total Debt fell 3.4% to $42.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.3 million through Jan 2026, down 3.4% year-over-year, with the annual reading at $41.1 million for FY2025, 3.38% down from the prior year.
  • Total Debt for Q1 2026 was $42.3 million at Kestra Medical Technologies, up from $41.9 million in the prior quarter.
  • The five-year high for Total Debt was $43.7 million in Q1 2025, with the low at $41.1 million in Q2 2025.
  • Average Total Debt over 3 years is $42.2 million, with a median of $42.1 million recorded in 2025.
  • The sharpest move saw Total Debt dropped 3.38% in 2025, then fell 3.4% in 2026.
  • Over 3 years, Total Debt stood at $42.5 million in 2024, then fell by 1.56% to $41.9 million in 2025, then increased by 0.93% to $42.3 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods came in at $42.3 million, $41.9 million, and $41.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.